Driving discovery and solving challenges for partners across nucleic acid–based medicine, spanning LNP formulation and RNA chemistry | www.etherna.be We are a nucleic acid–based medicine technology platform company, partnering with pharma and biotech industry players with an emerging or established interest in nucleic acid therapeutics. Our expert team supports start‑up, early‑stage, and late‑stage projects by using our proprietary platforms across RNA chemistry, LNP formulation, and process technologies to drive new pipeline development or resolve manufacturing challenges for our partners.
Looking for a particular eTheRNA employee's phone or email?
eTheRNA Questions
The eTheRNA annual revenue was $14.8 million in 2026.
Phil Challis is the Senior Vice President Manufacturing of eTheRNA.
53 people are employed at eTheRNA.
eTheRNA is based in Niel, Flanders.
The NAICS codes for eTheRNA are [5417, 541, 54, 54171, 541714].
The SIC codes for eTheRNA are [87, 873].
Top eTheRNA Employees
-
Phil Challis
Senior Vice President Manufacturing at eTheRNA
Leuven, Flanders, BE21 -
15+
-
11
-
Lien Vangansewinkel
Financial Director at eTheRNA
Zaventem, BE2 -
1
-
Shrinivas Dumbre
Associate Director Medicinal Chemistry-Technology and Innovation at eTheRNA
Scherpenheuvel-Zichem, BE2
Related Companies
